Proscia, a company developing digital and AI-based pathology software, has raised $50 million in a Series C funding round to expand the adoption of its Concentriq platform. The new investment brings the company’s total funding to $130 million as demand grows for more efficient diagnostic tools in oncology and other disease areas. The funding round…